Transcriptome data of multiple sclerosis patients receiving fingolimod therapy [HTA-2_0, CD19+ cells, gene level]
Ontology highlight
ABSTRACT: We analyzed the gene expression patterns of different blood cell types before and during fingolimod treatment in a group of patients with relapsing-remitting multiple sclerosis (RRMS). Affymetrix Human Transcriptome Arrays (HTA) 2.0 were used to obtain gene expression profiles of immune cell populations from 10 RRMS patients within the first 3 months of fingolimod treatment. This GEO entry provides the Affymetrix HTA 2.0 microarray data of peripheral blood CD19+ cells, preprocessed according to the gene level workflow.
ORGANISM(S): Homo sapiens
PROVIDER: GSE81604 | GEO | 2016/05/20
SECONDARY ACCESSION(S): PRJNA322150
REPOSITORIES: GEO
ACCESS DATA